Cardiovascular Risk Factors in Adults with Atopic Dermatitis: A Cross-sectional Study
DOI:
https://doi.org/10.2340/actadv.v106.adv-2026-0452Keywords:
Atopic dermatitis, Arterial stiffness, Blood pressure, Biomarkers, Cardiovascular risk, LifestyleAbstract
Atopic dermatitis (AD) is a chronic inflammatory skin disease linked to systemic comorbidities, although its relationship with cardiovascular risk) remains controversial. The main objective of this study was to evaluate cardiovascular risk-related factors in AD and explore associations with disease severity. A cross-sectional study including adults with AD and healthy controls was conducted. Cardiovascular risk assessment included anthropometric, lifestyle, vascular and laboratory data, with global risk estimated using the PREVENT equations. The study included 100 adults (50 AD patients and 50 controls). Patients had moderate-to-severe disease (SCORAD 49.19±16.41). Compared with controls, AD patients showed higher BMI (27.25 vs 24.63 kg/m², p=0.01), lower Mediterranean diet adherence (p<0.001) and reduced physical activity (p=0.03). Mean arterial pressure (103.67 vs 93.55 mmHg, p=0.001), LDH (215.31 vs 183.88 IU/L; p=0.008) and CRP (7.90 vs 0.84 mg/L, p=0.05) were significantly higher in patients. Higher v-IGA scores were associated with increased fasting glucose and heart rate. Estimated 10 year cardiovascular risk was significantly higher in AD than in controls (p=0.04). Overall, AD patients exhibit an unfavourable cardiometabolic profile. Greater disease severity may be linked to vascular alterations, supporting the need for cardiovascular assessment in AD management.
Downloads
References
Chan KR, Keddie SH, Flohr C, Tsoi MF. Prevalence of atopic dermatitis in the United States from 2021 to 2024: data from the National Health Interview Survey. J Am Acad Dermatol 2026; 94: 633–635. DOI: https://doi.org/10.1016/j.jaad.2025.10.022
Ho MJ, Sultana R, Choo K, Lee HY. Cumulative life course impairment in moderate-to-severe atopic dermatitis: cross-sectional study in Singapore. Dermatology 2025; 241: 425–436. DOI: https://doi.org/10.1159/000548368
Rerknimitr P, Otsuka A, Nakashima C, Kabashima K. The etiopathogenesis of atopic dermatitis: barrier disruption, immunological derangement, and pruritus. Inflamm Regen 2017; 37: 14. DOI: https://doi.org/10.1186/s41232-017-0044-7
Morąg B, Kozubek P, Gomułka K. Obesity and selected allergic and immunological diseases—etiopathogenesis, course and management. Nutrients 2023; 15: 37686844. DOI: https://doi.org/10.3390/nu15173813
Matwiejuk M, Myśliwiec H, Mikłosz A, Chabowski A, Flisiak I. Is atopic dermatitis associated with systemic metabolic disturbances? A systematic review. IJMS 2025; 26: 5884. DOI: https://doi.org/10.3390/ijms26125884
Katamanin OM, Tan IJ, Barry J, Jafferany M. Role of inflammation and cytokine dysregulation in depression in patients with inflammatory skin conditions. Am J Clin Dermatol 2025; 26: 35–43. DOI: https://doi.org/10.1007/s40257-024-00905-9
Esposito M, Giunta A, De Berardinis A, Magnanimi LM, Fargnoli MC, Patruno C, et al. Dermatologic comorbidities associated with atopic dermatitis towards a shared therapeutical approach: a narrative review. Dermatol Ther 2025; 15: 3495–3511. DOI: https://doi.org/10.1007/s13555-025-01536-6
Uehara M, Sugiura H, Tanaka K. Rarity of hypertension in adult patients with atopic dermatitis. Br J Dermatol 2002; 146: 631–635. DOI: https://doi.org/10.1046/j.1365-2133.2002.04717.x
Andersen YMF, Egeberg A, Gislason GH, Hansen PR, Skov L, Thyssen JP. Risk of myocardial infarction, ischemic stroke, and cardiovascular death in patients with atopic dermatitis. J Allergy Clin Immunol 2016; 138: 310–312. DOI: https://doi.org/10.1016/j.jaci.2016.01.015
Yuan M, Cao WF, Xie XF, Zhou HY, Wu XM. Relationship of atopic dermatitis with stroke and myocardial infarction. Medicine 2018; 97: e13512. DOI: https://doi.org/10.1097/MD.0000000000013512
Berna-Rico E, Pérez-García B, Abbad-Jaime de Aragón C, Neria F, Monge D, Pérez-Bootello J, et al. Subclinical atherosclerosis is increased in moderate-to-severe atopic dermatitis. J Eur Acad Dermatol Venereol 2025; 39: e1032–e1035. DOI: https://doi.org/10.1111/jdv.20813
Silverwood RJ, Forbes HJ, Abuabara K, Ascott A, Schmidt M, Schmidt SAJ, et al. Severe and predominantly active atopic eczema in adulthood and long term risk of cardiovascular disease: population based cohort study. BMJ 2018; 361: k1786. DOI: https://doi.org/10.1136/bmj.k1786
Fehr D, Huynh-Tran VH, Maintz L, Niederseer D, Ameri M, Dreher A, et al. Deciphering the connection between atopic dermatitis and cardiovascular diseases: analysis of clinical associations and cardiometabolic proteins. Allergy 2025; 80: 2187–2200. DOI: https://doi.org/10.1111/all.16588
Müller S, Maintz L, Bieber T. Treatment of atopic dermatitis: recently approved drugs and advanced clinical development programs. Allergy 2024; 79: 1501–1515. DOI: https://doi.org/10.1111/all.16009
Oh J, Kim S, Kim MS, Abate YH, Abd ElHafeez S, Abdelkader A, et al. Global, regional, and national burden of asthma and atopic dermatitis, 1990–2021, and projections to 2050: a systematic analysis of the Global Burden of Disease Study 2021. Lancet Respir Med 2025; 13: 425–446. DOI: https://doi.org/10.1016/S2213-2600(25)00003-7
Haag C, Alexis A, Aoki V, Bissonnette R, Blauvelt A, Chovatiya R, et al. A practical guide to using oral Janus kinase inhibitors for atopic dermatitis from the International Eczema Council. Br J Dermatol 2024; 192: 135–143. DOI: https://doi.org/10.1093/bjd/ljae342
Khan SS, Matsushita K, Sang Y, Ballew SH, Grams ME, Surapaneni A, et al. Development and validation of the American Heart Association’s PREVENT equations. Circulation 2024; 149: 430–449. DOI: https://doi.org/10.1161/CIRCULATIONAHA.123.067626
Yew YW, Loh M, Thng STG, Chambers JC. Investigating causal relationships between Body Mass Index and risk of atopic dermatitis: a Mendelian randomization analysis. Sci Rep 2020; 10: 15279. DOI: https://doi.org/10.1038/s41598-020-72301-2
Obesity. [cited 2025 October 3].
Bastard JP, Maachi M, Lagathu C, Kim MJ, Caron M, Vidal H, et al. Recent advances in the relationship between obesity, inflammation, and insulin resistance. Eur Cytokine Netw 2006; 17: 4–12.
Yang S, Zhu T, Wakefield JS, Mauro TM, Elias PM, Man MQ. Link between obesity and atopic dermatitis: does obesity predispose to atopic dermatitis, or vice versa? Exp Dermatol 2023; 32: 975–985. DOI: https://doi.org/10.1111/exd.14801
Salava A, Salo V, Leppänen J, Lauerma A, Remitz A. Factors associated with severity of atopic dermatitis - a Finnish cross-sectional study. J Eur Acad Dermatol Venereol 2022; 36: 2130–2139. DOI: https://doi.org/10.1111/jdv.18378
la Torre R de, Ureña-Paniego C, Arias-Santiago S, Montero-Vílchez T. Impact of the Mediterranean diet and physical activity on the severity of atopic dermatitis. Dermatitis 2025: 17103568251376645. DOI: https://doi.org/10.1177/17103568251376645
Kesik F, Dogan-Gunaydin S, Fisunoglu M. The impact of diet on hidradenitis suppurativa severity: a cross-sectional case-control study. Medicina 2024; 60: 39768986. DOI: https://doi.org/10.3390/medicina60122107
Kupczyk D, Bilski R, Szeleszczuk Ł, Mądra-Gackowska K, Studzińska R. The role of diet in modulating inflammation and oxidative stress in rheumatoid arthritis, ankylosing spondylitis, and psoriatic arthritis. Nutrients 2025; 17: 1603. DOI: https://doi.org/10.3390/nu17091603
Lorite-Fuentes I, Montero-Vilchez T, Arias-Santiago S, Molina-Leyva A. Potential benefits of the Mediterranean diet and physical activity in patients with hidradenitis suppurativa: a cross-sectional study in a Spanish population. Nutrients 2022; 14: 551. DOI: https://doi.org/10.3390/nu14030551
Kwon YJ, Lee HS, Lee JW. Association between dietary patterns and cardiovascular mortality in patients with metabolic dysfunction-associated steatotic liver disease. Endocrine 2025; 90: 558–569. DOI: https://doi.org/10.1007/s12020-025-04365-x
Huang B, Lin C, Feng Y, Cai S, Zhao M, Hu C, et al. Association between physical activity domains and cardiovascular diseases among US adults: evidence from NHANES 2007–2020. Sci Rep 2025; 15: 35341. DOI: https://doi.org/10.1038/s41598-025-19419-3
Frølunde AS, Drljevic-Nielsen A, Vestergaard C. Atopic dermatitis, hypertension, and cardiovascular risk: an appraisal of the evidence. Ital J Dermatol Venerol 2025; 160: 494–500. DOI: https://doi.org/10.23736/S2784-8671.25.08041-7
Hametner B, Wassertheurer S, Mayer CC, Danninger K, Binder RK, Weber T. Aortic pulse wave velocity predicts cardiovascular events and mortality in patients undergoing coronary angiography: a comparison of invasive measurements and noninvasive estimates. Hypertension 2021; 77: 571–581. DOI: https://doi.org/10.1161/HYPERTENSIONAHA.120.15336
Agoglia L, Peixoto H, Cardoso AC, Barbosa L, Victer CSXL, Carneiro S, et al. Psoriasis and cardiovascular risk: associated and protective factors. An Bras Dermatol 2025; 100: 456–461. DOI: https://doi.org/10.1016/j.abd.2024.07.013
Shalom G, Dreiher J, Kridin K, Horev A, Khoury R, Battat E, et al. Atopic dermatitis and the metabolic syndrome: a cross-sectional study of 116 816 patients. J Eur Acad Dermatol Venereol 2019; 33: 1762–1767. DOI: https://doi.org/10.1111/jdv.15642
Zhong X, Huang D, Chen R, Yao L, Ma R, Yu Y, et al. Positive association between insulin resistance and fatty liver disease in psoriasis: evidence from a cross-sectional study. Front Immunol 2024; 15: 1388967. DOI: https://doi.org/10.3389/fimmu.2024.1388967
Zhang Y, Wei Q, Chen Q. Potential shared mechanisms in atopic dermatitis and type 2 diabetes identified via transcriptomic and machine learning approaches. Sci Rep 2024; 14: 39681684. DOI: https://doi.org/10.1038/s41598-024-82732-w
Ascott A, Mulick A, Yu AM, Prieto-Merino D, Schmidt M, Abuabara K, et al. Atopic eczema and major cardiovascular outcomes: a systematic review and meta-analysis of population-based studies. J Allergy Clin Immunol 2019; 143: 1821–1829. DOI: https://doi.org/10.1016/j.jaci.2018.11.030
Aune D, Sen A, ó’Hartaigh B, Janszky I, Romundstad PR, Tonstad S, et al. Resting heart rate and the risk of cardiovascular disease, total cancer, and all-cause mortality - a systematic review and dose-response meta-analysis of prospective studies. Nutr Metab Cardiovasc Dis 2017; 27: 504–517. DOI: https://doi.org/10.1016/j.numecd.2017.04.004
Brito Díaz B, Alemán Sánchez JJ, Cabrera de León A. Frecuencia cardiaca en reposo y enfermedad cardiovascular. Med Clín 2014; 143: 34–38. DOI: https://doi.org/10.1016/j.medcli.2013.05.034
Gagliardi ACM, Miname MH, Santos RD. Uric acid: A marker of increased cardiovascular risk. Atherosclerosis 2009; 202: 11–17. DOI: https://doi.org/10.1016/j.atherosclerosis.2008.05.022
Sundar Ray C, Singh B, Jena I, Behera S, Ray S. Low alkaline phosphatase (ALP) in adult population: an indicator of zinc (Zn) and magnesium (Mg) deficiency. Curr Res Nutr Food Sci 2017; 5: 347–352. DOI: https://doi.org/10.12944/CRNFSJ.5.3.20
Additional Files
Published
How to Cite
License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All digitalized ActaDV contents is available freely online. The Society for Publication of Acta Dermato-Venereologica owns the copyright for all material published until volume 88 (2008) and as from volume 89 (2009) the journal has been published fully Open Access, meaning the authors retain copyright to their work.
Unless otherwise specified, all Open Access articles are published under CC-BY-NC licences, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material for non-commercial purposes, provided proper attribution to the original work.
